For­mer As­traZeneca ex­ec com­mit­ted in­sid­er trad­ing on land­mark 2019 En­her­tu deal, SEC al­leges

A for­mer As­traZeneca em­ploy­ee al­leged­ly en­gaged in in­sid­er trad­ing while at the Big Phar­ma, ac­cord­ing to an SEC com­plaint sub­mit­ted last week.

In March 2019 …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER